Filing Details

Accession Number:
0001752836-21-000015
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-19 16:08:34
Reporting Period:
2021-01-14
Accepted Time:
2021-01-19 16:08:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1752836 Covetrus Inc. CVET Retail-Drug Stores And Proprietary Stores (5912) 831448706
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1765583 Jr. C. Anthony Providenti 7 Custom House Street
Portland ME 04101
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-14 10,218 $0.00 20,540 No 4 M Direct
Common Stock Disposition 2021-01-14 3,639 $38.42 16,901 No 4 F Direct
Common Stock Disposition 2021-01-15 2,400 $36.83 14,501 No 4 S Direct
Common Stock Disposition 2021-01-15 2,600 $36.75 11,901 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2021-01-14 10,218 $0.00 10,218 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,438 2023-01-14 No 4 M Direct
Footnotes
  1. Sale pursuant to 10b5-1 Plan dated December 15, 2020.
  2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $36.09 - $38.08. The Reporting Person hereby undertakes, upon request by the Commission staff, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  3. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $36.32 - $38.08. The Reporting Person hereby undertakes, upon request by the Commission staff, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  4. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock or the cash value thereof.
  5. Subject to the Reporting Person's continuous service as an employee of the Issuer, the RSUs will vest in three equal annual installments beginning on January 14, 2021.